What is Mycobacterium avium Complex (MAC)?
Mycobacterium avium complex (MAC) is a group of slow-growing nontuberculous mycobacteria (NTM) that includes at least two primary species—M. avium and M. intracellulare—which are the most common NTM pathogens causing pulmonary and disseminated disease in humans. 1
Taxonomy and Species Composition
MAC consists of at least 12 validly published species, with the most clinically relevant being:
- M. avium (more important in disseminated disease)
- M. intracellulare (more common in respiratory infections)
- M. chimaera (increasingly recognized as a distinct pathogen)
These species cannot be differentiated using traditional physical and biochemical tests, requiring DNA probes or molecular methods for species-level identification 1. However, routine separation of MAC isolates into specific species provides no current prognostic or treatment advantage, though this may change with future research 1.
Key Distinction from Microbacterium
MAC belongs to the genus Mycobacterium, not Microbacterium—these are entirely different bacterial genera. Mycobacterium species are acid-fast bacilli with unique cell wall structures, while Microbacterium species are unrelated environmental bacteria. This distinction is critical for proper diagnosis and treatment.
Environmental Reservoir and Transmission
MAC organisms are ubiquitous environmental pathogens found in:
- Natural water sources (fresh and saltwater)
- Soil
- Indoor water systems, pools, and hot tubs
- Recirculating hot-water systems 1
Person-to-person transmission does not occur, and there is no evidence of animal-to-human transmission 1. Patients acquire MAC through environmental exposure, particularly from aerosolized water sources.
Clinical Disease Patterns
Pulmonary Disease (Two Distinct Forms)
1. Fibrocavitary Disease:
- Occurs in males in their late 40s-50s
- Associated with smoking and alcohol use
- Presents with apical cavitary lung disease
- Progressive within 1-2 years if untreated
- Can lead to respiratory failure 1
2. Nodular Bronchiectatic Disease ("Lady Windermere Syndrome"):
- Predominantly affects postmenopausal, nonsmoking white females
- Involves right middle lobe or lingula
- Shows multifocal bronchiectasis with small nodules
- Much slower progression than cavitary disease 1
Disseminated Disease
Occurs almost exclusively in patients with advanced HIV infection (CD4 count <50 cells/μL), presenting with:
- Fever (80% of cases)
- Night sweats (35%)
- Weight loss (25%)
- Abdominal pain or diarrhea
- Severe anemia (hematocrit <25%)
- Elevated alkaline phosphatase 1, 2
M. avium is the predominant species in disseminated disease, while M. intracellulare rarely causes dissemination despite being more common in pulmonary infections 1.
Diagnostic Criteria
The ATS/IDSA criteria require both clinical and microbiologic evidence 1:
Clinical Requirements:
- Pulmonary symptoms with nodular/cavitary opacities on chest X-ray or multifocal bronchiectasis with nodules on HRCT
- Exclusion of other diagnoses
Microbiologic Requirements (any one):
- Positive cultures from ≥2 separate sputum samples
- Positive culture from ≥1 bronchial wash/lavage
- Lung biopsy with granulomatous inflammation plus positive NTM culture
Critical caveat: Making the diagnosis does not automatically necessitate treatment—this decision depends on individual risk-benefit assessment 1.
Laboratory Identification
- Specimens should be cultured on both solid and liquid media
- Incubation for minimum 6 weeks required 3, 4
- Species identification uses DNA probes, HPLC, or gene sequencing
- For CF patients and clinical purposes, identification to MAC level (rather than individual species) is acceptable 3, 4
Geographic and Epidemiologic Notes
MAC pulmonary disease appears more common in the southeastern United States, though comprehensive data is limited 1. Recent genomic studies show high diversity within MAC species, with evidence of trans-European and trans-continental clustering, suggesting potential transmission pathways that remain poorly understood 5.